DE60234535D1 - Peptid aufreinigung - Google Patents

Peptid aufreinigung

Info

Publication number
DE60234535D1
DE60234535D1 DE60234535T DE60234535T DE60234535D1 DE 60234535 D1 DE60234535 D1 DE 60234535D1 DE 60234535 T DE60234535 T DE 60234535T DE 60234535 T DE60234535 T DE 60234535T DE 60234535 D1 DE60234535 D1 DE 60234535D1
Authority
DE
Germany
Prior art keywords
sub
solvent
water
mixture
decapeptide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60234535T
Other languages
German (de)
English (en)
Inventor
Jon H Rasmussen
Palle H Rasmussen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
CARLBIOTECH Ltd AS
Polypeptide Laboratories AS
Original Assignee
CARLBIOTECH Ltd AS
Polypeptide Laboratories AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by CARLBIOTECH Ltd AS, Polypeptide Laboratories AS filed Critical CARLBIOTECH Ltd AS
Application granted granted Critical
Publication of DE60234535D1 publication Critical patent/DE60234535D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • C07K7/06Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14Extraction; Separation; Purification
    • C07K1/30Extraction; Separation; Purification by precipitation

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DE60234535T 2001-12-29 2002-12-23 Peptid aufreinigung Expired - Lifetime DE60234535D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE0104462A SE0104462D0 (sv) 2001-12-29 2001-12-29 Peptide purifcation (Peptidrening)
PCT/IB2002/005581 WO2003055900A1 (en) 2001-12-29 2002-12-23 Peptide purification

Publications (1)

Publication Number Publication Date
DE60234535D1 true DE60234535D1 (de) 2010-01-07

Family

ID=20286556

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60234535T Expired - Lifetime DE60234535D1 (de) 2001-12-29 2002-12-23 Peptid aufreinigung

Country Status (18)

Country Link
US (1) US7057014B2 (enExample)
EP (1) EP1468009B1 (enExample)
JP (1) JP4378173B2 (enExample)
KR (1) KR100880828B1 (enExample)
CN (1) CN1272341C (enExample)
AT (1) ATE449784T1 (enExample)
AU (1) AU2002347550B2 (enExample)
CA (1) CA2471717C (enExample)
DE (1) DE60234535D1 (enExample)
DK (1) DK1468009T3 (enExample)
ES (1) ES2350880T3 (enExample)
IL (2) IL162789A0 (enExample)
NO (1) NO329024B1 (enExample)
NZ (1) NZ534151A (enExample)
RU (1) RU2303040C2 (enExample)
SE (1) SE0104462D0 (enExample)
WO (1) WO2003055900A1 (enExample)
ZA (1) ZA200405135B (enExample)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1359722A1 (en) * 2002-03-27 2003-11-05 BRITISH TELECOMMUNICATIONS public limited company Data streaming system and method
KR101346886B1 (ko) 2005-01-21 2014-01-02 아스텍스 테라퓨틱스 리미티드 제약 화합물
JP5528806B2 (ja) 2006-10-12 2014-06-25 アステックス、セラピューティックス、リミテッド 複合薬剤
EP2073807A1 (en) 2006-10-12 2009-07-01 Astex Therapeutics Limited Pharmaceutical combinations
US9051349B2 (en) 2007-11-21 2015-06-09 Alba Therapeutics Corporation Larazotide acetate compositions
EP2062909A1 (en) * 2007-11-21 2009-05-27 SOLVAY (Société Anonyme) Peptide production and purification process
US20120149868A1 (en) * 2008-05-15 2012-06-14 Novo Nordisk A/S Purification of peptides prepared by solid phase synthesis
ES2439998T3 (es) * 2009-04-10 2014-01-27 Corden Pharma Colorado, Inc. Procedimiento para aislar linaclotida
ES2819573T3 (es) 2012-12-13 2021-04-16 Immunomedics Inc Método para producir inmunoconjugados de anticuerpo-SN-38 con un enlazador CL2A
PL2900277T3 (pl) 2012-12-13 2022-05-16 Immunomedics, Inc. Dawkowanie immunokoniugatów przeciwciał i sn-38 dla poprawy skuteczności i zmniejszenia toksyczności
US9931417B2 (en) 2012-12-13 2018-04-03 Immunomedics, Inc. Antibody-SN-38 immunoconjugates with a CL2A linker
EP3024460B1 (en) * 2013-07-23 2020-07-22 Immunomedics, Inc. Method for producing antibody-sn-38 immunoconjugates with a cl2a linker
AU2017257254B2 (en) 2016-04-27 2022-02-24 Immunomedics, Inc. Efficacy of anti-Trop-2-SN-38 antibody drug conjugates for therapy of tumors relapsed/refractory to checkpoint inhibitors
RU2758234C2 (ru) 2017-03-27 2021-10-26 Иммьюномедикс, Инк. ЛЕЧЕНИЕ ТРИЖДЫ НЕГАТИВНОГО РАКА МОЛОЧНОЙ ЖЕЛЕЗЫ, ХАРАКТЕРИЗУЮЩЕГОСЯ ЭКСПРЕССИЕЙ Trop-2, С ПОМОЩЬЮ САЦИТУЗУМАБА ГОВИТЕКАНА И ИНГИБИТОРА Rad51
WO2018187074A1 (en) 2017-04-03 2018-10-11 Immunomedics, Inc. Subcutaneous administration of antibody-drug conjugates for cancer therapy
CN113952944B (zh) * 2021-12-23 2022-03-29 浙江湃肽生物有限公司深圳分公司 一种纯化九肽-1的方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8317697D0 (en) * 1983-06-29 1983-08-03 Shell Int Research Dissolution of peptides in non-aqueous and mixed non-aqueous/aqueous solvents
DE4001238A1 (de) * 1990-01-18 1991-07-25 Basf Ag Verfahren zur anreicherung bzw. reinigung von biomolekuelen
DE19544212A1 (de) * 1995-11-28 1997-06-05 Asta Medica Ag Neue LH-RH-Antagonisten mit verbesserter Wirkung
DE19813849A1 (de) * 1998-03-27 1999-09-30 Degussa Verfahren zur einstufigen Umsalzung und Aufreinigung von Oligopeptiden
EP0998940A1 (en) 1998-09-30 2000-05-10 Laboratoire Theramex Pharmaceutical compositions based on alpha-cyclodextrin for the oral administration of LH-RH analogues
DE19911771B4 (de) * 1999-03-17 2006-03-30 Zentaris Gmbh LHRH-Antagonist, Verfahren zu seiner Herstellung und seiner Verwendung

Also Published As

Publication number Publication date
US7057014B2 (en) 2006-06-06
EP1468009A1 (en) 2004-10-20
JP2005515217A (ja) 2005-05-26
AU2002347550A1 (en) 2003-07-15
ES2350880T3 (es) 2011-01-27
HK1076112A1 (en) 2006-01-06
KR20040090966A (ko) 2004-10-27
KR100880828B1 (ko) 2009-01-30
CA2471717C (en) 2013-06-18
NZ534151A (en) 2007-05-31
WO2003055900A1 (en) 2003-07-10
CN1272341C (zh) 2006-08-30
RU2004119965A (ru) 2006-01-10
ATE449784T1 (de) 2009-12-15
IL162789A0 (en) 2005-11-20
CN1625561A (zh) 2005-06-08
NO20043046L (no) 2004-08-30
SE0104462D0 (sv) 2001-12-29
EP1468009B1 (en) 2009-11-25
US20060014694A1 (en) 2006-01-19
ZA200405135B (en) 2005-08-31
AU2002347550B2 (en) 2008-01-03
DK1468009T3 (da) 2010-04-06
IL162789A (en) 2010-04-29
CA2471717A1 (en) 2003-07-10
RU2303040C2 (ru) 2007-07-20
JP4378173B2 (ja) 2009-12-02
NO329024B1 (no) 2010-08-02

Similar Documents

Publication Publication Date Title
ATE449784T1 (de) Peptid aufreinigung
MY142836A (en) Self-extinguishing catalyst composition with monocarboxylic acid ester internal donor and propylene polymerization process
SI1515962T1 (sl) Postopek za pripravo dioksan estrov ocetne kisline
DK0925065T3 (da) Vandblandbare erythromycinsammensætninger
US4482486A (en) Analogs of vasopressin
CS212284B2 (en) Method of making the 1,1-dioxides of the acetoxymethylpenam derivatives
Ko et al. Generation of Diphenyldiazomethane by Oxidation of Benzophenone Hydrazone with Magtrieve [TM]
AU5421299A (en) Substituted cinnamic acids and cinnamic acid esters
ATE258911T1 (de) Verfahren zur herstellung von alkoxyzimtsäureester
Tabushi et al. Photoreduction of keto carboxylic acid derivatives to oxyacid derivatives catalyzed by ZnTPPS [zinc tetraphenylporphyrintetrasulfonate]-quinolinium-3-carboxamide-CTAB micelle
CA2573129A1 (en) Process for preparing levofloxacin or its hydrate
CA1233171A (en) Process for the preparation of 6,6- dibromopenicillanic acid 1,1-dioxide
RU2000114008A (ru) Способ выделения кислот из углеводородных смесей
KR890014575A (ko) α-L-아스파르틸-L-페닐알라닌 메틸에스테르의 분리방법
AU5217596A (en) Preparation and use of 7-((2-carboalkoxy-1-methylethenyl) amino)3-hydroxymethy l-3-cephem-4-carboxylic acids
Kost et al. α-arylmethylamino acids
Maclaren P-Methoxybenzyl esters of amino acids-their preparation and use in peptide synthesis
NO920158L (no) Fremgangsmaate for oekning av forholdet for alfa til beta ien aspartam-koblingsreaksjon
RU95120710A (ru) Способ герметизации трубопровода

Legal Events

Date Code Title Description
8364 No opposition during term of opposition